AN ancient disease has been making a comeback and it could be caused by an acid reflux drug, a new study has warned. Health ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...

To determine whether treatment of occult acid reflux is worthwhile for asthma patients, 412 adults with inadequately controlled asthma were randomized to receive the proton-pump inhibitor (PPI ...

The rising prevalence of gastrointestinal disorders and increased awareness of rare diseases are driving the ...

Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a ...

A common acid reflux medication taken by 15 per cent of the UK population could be contributing to a rise in scurvy cases, ...

Researchers from both Johns Hopkins Medicine and Yale University collaborated on the development and application of a diagnostic model to detect acute interstitial nephritis (AIN) in patients, which c ...

More than 54% of people in the United States who take heartburn medications called proton pump inhibitors (PPIs) daily still have acid reflux symptoms. Additionally, PPIs do not work for everyone.

The following is a summary of “Brain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, ...

Pholosong presented two projects out of the 11 and won first and second prizes. “The project that obtained the prize investigated the chronic use of proton-pump inhibitors in patients attending ...

New Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Phathom is in the final stages of obtaining FDA feedback on the Phase 2 study and program investigating VOQUEZNA as a potential treatment for Eosinophilic Esophagitis (EoE) in adults and adolescents, ...